STEPHANIE COOPER: Open Payments
NPI 1487052429 · ROGERSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 29 payments from 11 companies in 2025. Trend: 2023 $855 · 2024 $877 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $153 |
| GlaxoSmithKline, LLC. | 4 | $70 |
| ABBVIE INC. | 3 | $62 |
| Novo Nordisk Inc | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Xeris Pharmaceuticals, Inc. | 2 | $33 |
| Lilly USA, LLC | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Exact Sciences Corporation | 1 | $16 |
| PFIZER INC. | 1 | $14 |
Products named: TRELEGY ELLIPTA, BREZTRI, Ozempic, AIRSUPRA, FARXIGA, QULIPTA, CAPLYTA, GVOKE HYPOPEN.
Industry payments across TN — which companies pay providers there.
